<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38627327</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-0755</ISSN><JournalIssue CitedMedium="Internet"><Volume>72</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Immunologic research</Title><ISOAbbreviation>Immunol Res</ISOAbbreviation></Journal><ArticleTitle>Cluster analysis of long COVID symptoms for deciphering a syndrome and its long-term consequence.</ArticleTitle><Pagination><StartPage>605</StartPage><EndPage>613</EndPage><MedlinePgn>605-613</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12026-024-09465-w</ELocationID><Abstract><AbstractText>The long-term symptoms of COVID-19 are the subject of public and scientific discussions. Understanding how those long COVID symptoms co-occur in clusters of syndromes may indicate the pathogenic mechanisms of long COVID. Our study objective was to cluster the different long COVID symptoms. We included persons who had a COVID-19 and assessed long-term symptoms (at least 4&#xa0;weeks after first symptoms). Hierarchical clustering was applied to the symptoms as well as to the participants based on the Euclidean distance h of the log-values of the answers on symptom severity. The distribution of clusters within our cohort is shown in a heat map.From September 2021 to November 2023, 2371 persons with persisting long COVID symptoms participated in the study. Self-assessed long COVID symptoms were assigned to three symptom clusters. Cluster A unites rheumatological and neurological symptoms, cluster B includes neuro-psychological symptoms together with cardiorespiratory symptoms, and a third cluster C shows an association of general infection signs, dermatological and otology symptoms. A high proportion of the participants (n&#x2009;=&#x2009;1424) showed symptoms of all three clusters. Clustering of long COVID symptoms reveals similarities to the symptomatology of already described syndromes such as the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) or rheumatological autoinflammatory diseases. Further research may identify serological parameters or clinical risk factors associated with the shown clusters and might improve our understanding of long COVID as a systemic disease. Furthermore, multimodal treatments can be developed and scaled for symptom clusters and associated impairments.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Niewolik</LastName><ForeName>J</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-7367-9286</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. niewolik.jacqueline@mh-hannover.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Mikuteit</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dean's Office - Curriculum Development, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Klawitter</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Information Engineering, Ostfalia University of Applied Sciences, Wolfenb&#xfc;ttel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schr&#xf6;der</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of General Practice, University Medical Center G&#xf6;ttingen, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>St&#xf6;lting</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vahldiek</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute for Information Engineering, Ostfalia University of Applied Sciences, Wolfenb&#xfc;ttel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heinemann</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General Practice, University Medical Center G&#xf6;ttingen, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;ller</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of General Practice, University Medical Center G&#xf6;ttingen, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Behrens</LastName><ForeName>Gmn</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Infection Research (DZIF), Partner Site Hannover, Brunswick, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Klawonn</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute for Information Engineering, Ostfalia University of Applied Sciences, Wolfenb&#xfc;ttel, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Helmholtz Centre for Infection Research, Brunswick, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Dopfer-Jablonka</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Infection Research (DZIF), Partner Site Hannover, Brunswick, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Steffens</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dean's Office - Curriculum Development, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>ZW7-85152953</GrantID><Agency>European Regional Development Fund</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Immunol Res</MedlineTA><NlmUniqueID>8611087</NlmUniqueID><ISSNLinking>0257-277X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cluster analysis</Keyword><Keyword MajorTopicYN="N">Long COVID symptoms</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>27</Day><Hour>9</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>17</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>16</Day><Hour>23</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38627327</ArticleId><ArticleId IdType="pmc">PMC11347473</ArticleId><ArticleId IdType="doi">10.1007/s12026-024-09465-w</ArticleId><ArticleId IdType="pii">10.1007/s12026-024-09465-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nittas V, Gao M, West EA, Ballouz T, Menges D, Wulf Hanson S, Puhan MA. Long COVID through a public health lens: an umbrella review. Public Health Rev. 2022;43:1604501. 10.3389/phrs.2022.1604501. 10.3389/phrs.2022.1604501</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/phrs.2022.1604501</ArticleId><ArticleId IdType="pmc">PMC8963488</ArticleId><ArticleId IdType="pubmed">35359614</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V, Florencio LL, Cuadrado ML, Plaza-Manzano G, Navarro-Santana M. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. Eur J Intern Med. 2021;92:55&#x2013;70. 10.1016/j.ejim.2021.06.009. 10.1016/j.ejim.2021.06.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. Condition, WHO Clinical Case Definition Working Group on post-COVID-19. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2021. 10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q, Zheng B, Daines L, Sheikh A. Long-term sequelae of COVID-19: a systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens. 2022. 10.3390/pathogens11020269. 10.3390/pathogens11020269</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahanic S, Tymoszuk P, Ausserhofer D, Rass V, Pizzini A, Nordmeyer G, et al. Phenotyping of acute and persistent COVID-19 features in the outpatient setting: exploratory analysis of an international cross-sectional online survey. Clin Infect Dis. 2021. 10.1093/cid/ciab978.10.1093/cid/ciab978</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab978</ArticleId><ArticleId IdType="pmc">PMC8767855</ArticleId><ArticleId IdType="pubmed">34849652</ArticleId></ArticleIdList></Reference><Reference><Citation>Czepczor-Bernat K, Swami V, Modrzejewska A, Modrzejewska J. COVID-19-related stress and anxiety, body mass index, eating disorder symptomatology, and body image in women from Poland: a cluster analysis approach. Nutrients. 2021. 10.3390/nu13041384. 10.3390/nu13041384</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13041384</ArticleId><ArticleId IdType="pmc">PMC8073902</ArticleId><ArticleId IdType="pubmed">33924010</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirfazeli FS, Sarabi-Jamab A, Jahanbakhshi A, Kordi A, Javadnia P, Shariat SV, et al. Neuropsychiatric manifestations of COVID-19 can be clustered in three distinct symptom categories. Sci Rep. 2020;10:20957. 10.1038/s41598-020-78050-6. 10.1038/s41598-020-78050-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-78050-6</ArticleId><ArticleId IdType="pmc">PMC7708626</ArticleId><ArticleId IdType="pubmed">33262404</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuodi P, Gorelik Y, Gausi B, Bernstine T, Edelstein M. Characterization of post-COVID syndromes by symptom cluster and time period up to 12 months post-infection: a systematic review and meta-analysis. Int J Infect Dis. 2023;134:1&#x2013;7. 10.1016/j.ijid.2023.05.003. 10.1016/j.ijid.2023.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2023.05.003</ArticleId><ArticleId IdType="pubmed">37150350</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldhaber NH, Kohn JN, Ogan WS, Sitapati A, Longhurst CA, Wang A, et al. Deep dive into the long haul: analysis of symptom clusters and risk factors for post-acute sequelae of COVID-19 to inform clinical care. Int J Environ Res Public Health. 2022. 10.3390/ijerph192416841. 10.3390/ijerph192416841</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192416841</ArticleId><ArticleId IdType="pmc">PMC9778884</ArticleId><ArticleId IdType="pubmed">36554723</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchida T, Yoshimura N, Ishizuka K, Katayama K, Inoue Y, Hirose M, et al. Five cluster classifications of long COVID and their background factors: a cross-sectional study in Japan. Clin Exp Med. 2023;23:3663&#x2013;70. 10.1007/s10238-023-01057-6. 10.1007/s10238-023-01057-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-023-01057-6</ArticleId><ArticleId IdType="pmc">PMC10081305</ArticleId><ArticleId IdType="pubmed">37027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Del Ayuzo Valle NC, Perelman C, Sepulveda R, Rebolledo PA, et al. Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep. 2022;12:9950. 10.1038/s41598-022-13495-5. 10.1038/s41598-022-13495-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-13495-5</ArticleId><ArticleId IdType="pmc">PMC9226045</ArticleId><ArticleId IdType="pubmed">35739136</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddad A, Janda A, Renk H, Stich M, Frieh P, Kaier K, et al. Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: a prospective observational cohort study. EBioMedicine. 2022;84:104245. 10.1016/j.ebiom.2022.104245. 10.1016/j.ebiom.2022.104245</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104245</ArticleId><ArticleId IdType="pmc">PMC9495281</ArticleId><ArticleId IdType="pubmed">36155957</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. 10.1136/bmj.n136. 10.1136/bmj.n136</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Robert Koch-Institut. Long COVID. 2023. https://www.rki.de/SharedDocs/FAQ/NCOV2019/FAQ_Liste_Gesundheitliche_Langzeitfolgen.html. Accessed 30 Nov 2023.</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence. COVID-19 rapid guideline: managing the long-term effects of COVID-19; 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Lance GN, Williams WT. A general theory of classificatory sorting strategies: II. Clustering Syst. 1967. 10.1093/comjnl/10.3.271.10.1093/comjnl/10.3.271</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/comjnl/10.3.271</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing. 2021. https://www.R-project.org/</Citation></Reference><Reference><Citation>O&#x2019;Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al. The prevalence and long-term health effects of long COVID among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine. 2023;55:101762. 10.1016/j.eclinm.2022.101762. 10.1016/j.eclinm.2022.101762</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong-Chew RM, Rodr&#xed;guez Cabrera EX, Rodr&#xed;guez Valdez CA, Lomelin-Gascon J, Morales-Ju&#xe1;rez L, La Cerda MLR, de, et al. Symptom cluster analysis of long COVID-19 in patients discharged from the temporary COVID-19 hospital in Mexico City. Ther Adv Infect Dis. 2022;9:20499361211069264. 10.1177/20499361211069264. 10.1177/20499361211069264</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20499361211069264</ArticleId><ArticleId IdType="pmc">PMC8764618</ArticleId><ArticleId IdType="pubmed">35059196</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Pinto MD, Borelli JL, Mehrabadi MA, Abrihim H, Dutt N, et al. COVID symptoms, symptom clusters, and predictors for becoming a long-hauler: looking for clarity in the haze of the pandemic. medRxiv. 2021. 10.1101/2021.03.03.21252086.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9510954</ArticleId><ArticleId IdType="pubmed">36154716</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;llenmeister C, Stoelting A, Schr&#xf6;der D, Schmachtenberg T, Ritter S, El-Sayed I, et al. Evaluating feasibility, acceptance and beneficial effects of online occupational therapy in post COVID-19 condition (Long COVID): ErgoLoCo Study Protocol (Preprint). JMIR Research Protocols. 2023. 10.2196/50230</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11130769</ArticleId><ArticleId IdType="pubmed">38739435</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny G, McCann K, O&#x2019;Brien C, Savinelli S, Tinago W, Yousif O, et al. Identification of distinct long COVID clinical phenotypes through cluster analysis of self-reported symptoms. Open Forum Infect Dis. 2022;9:ofac060. 10.1093/ofid/ofac060. 10.1093/ofid/ofac060</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac060</ArticleId><ArticleId IdType="pmc">PMC8900926</ArticleId><ArticleId IdType="pubmed">35265728</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P, Casari G, Townsend L, O&#x2019;Farrelly C, Tancevski I, L&#xf6;ffler-Ragg J, et al. Studying severe long COVID to understand post-infectious disorders beyond COVID-19. Nat Med. 2022. 10.1038/s41591-022-01766-7. 10.1038/s41591-022-01766-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01766-7</ArticleId><ArticleId IdType="pubmed">35383311</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong TL, Weitzer DJ. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)-a systemic review and comparison of clinical presentation and symptomatology. Medicina (Kaunas). 2021. 10.3390/medicina57050418. 10.3390/medicina57050418</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>